Tokyo, May 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061424) titled 'Minimal detectable change in cognitive assessment in patients with subacute stroke' on May 1.
Study Type:
Observational
Primary Sponsor:
Institute - Tokyo Metropolitan University
Condition:
Condition - Stroke
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to clarify the measurement errors and MDC of the MoCA and MMSE in subacute stroke patients stratified by severity.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Individuals who can remain seated for at least 15 minutes
Ages 18 to 90
Individuals diagnosed with a stroke by a physician based on CT or MRI results
Key exclusion criteria - Individuals diagnosed with dementia
Individuals diagnosed with apraxia
Individuals diagnosed with severe aphasia
Individuals diagnosed with severe hemispatial neglect
Target Size - 130
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 03 Month 20 Day
Date of IRB - 2026 Year 03 Month 20 Day
Anticipated trial start date - 2026 Year 05 Month 01 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070285
Disclaimer: Curated by HT Syndication.
